Dementia Today.net

Site updated at Wednesday, 22 June 2016

Living with Dementia

Amyloid Beta

New Direction In Alzheimer’s Research

In what they are calling a new direction in the study of Alzheimer’s disease, UC Santa Barbara scientists have made an important finding about what happens to brain cells that are destroyed in Alzheimer’s disease and related dementias. The results are published in the online version of The Journal of Biological Chemistry.

Stuart Feinstein,… New Direction In Alzheimer’s Research   



Protein in the brain could be a key target in controlling Alzheimer’s

A protein recently discovered in the brain could play a key role in regulating the creation of amyloid beta, the major component of plaques implicated in the development of Alzheimer’s disease, according to researchers at Temple University’s School of Medicine.

A group led by Domenico Pratico, professor of pharmacology and microbiology and immunology at… Protein in the brain could be a key target in controlling Alzheimer’s   



Amyloid beta in the brain of individuals with Alzheimer’s disease

The deposition of amyloid beta in the brain of individuals with Alzheimer’s disease is the focus of much research into both its cause and treatment.

While there may not be a consensus as to whether the deposition contributes to the disease or is a consequence of the disease, there is agreement that it is… Amyloid beta in the brain of individuals with Alzheimer’s disease   



Salk study finds diabetes raises levels of proteins linked to Alzheimer’s features

Growing evidence suggests that there may be a link between diabetes and Alzheimer’s disease, but the physiological mechanisms by which diabetes impacts brain function and cognition are not fully understood. In a new study published in Aging Cell, researchers at the Salk Institute for Biological Studies show, for the first time, that diabetes enhances… Salk study finds diabetes raises levels of proteins linked to Alzheimer’s features   



Atypical form of Alzheimer’s disease may be present in a more widespread number of patients

Neuroscientists at Mayo Clinic in Florida have defined a subtype of Alzheimer’s disease (AD) that they say is neither well recognized nor treated appropriately.

The variant, called hippocampal sparing AD, made up 11 percent of the 1,821 AD-confirmed brains examined by Mayo Clinic researchers - suggesting this subtype is relatively widespread in the general… Atypical form of Alzheimer’s disease may be present in a more widespread number of patients   



New amyloid-reducing compound could be a preventive measure against Alzheimer’s

Scientists at NYU Langone Medical Center have identified a compound, called 2-PMAP, in animal studies that reduced by more than half levels of amyloid proteins in the brain associated with Alzheimer’s disease. The researchers hope that someday a treatment based on the molecule could be used to ward off the neurodegenerative disease since it… New amyloid-reducing compound could be a preventive measure against Alzheimer’s   



Marijuana compound may offer treatment for Alzheimer’s disease

Extremely low levels of the compound in marijuana known as delta-9-tetrahydrocannabinol, or THC, may slow or halt the progression of Alzheimer’s disease, a recent study from neuroscientists at the University of South Florida shows.

Findings from the experiments, using a cellular model of Alzheimer’s disease, were reported online in the Journal of Alzheimer’s Disease.… Marijuana compound may offer treatment for Alzheimer’s disease   



Alzheimer’s researchers find clues to toxic forms of amyloid beta

Much of the research on Alzheimer’s disease has focused on the amyloid beta protein, which clumps together into sticky fibrils that form deposits in the brains of people with the disease. In recent years, attention has turned away from the fibrils themselves to an intermediate stage in the aggregation of amyloid beta. “Oligomers” consisting… Alzheimer’s researchers find clues to toxic forms of amyloid beta   



Parkinson’s Disease Dementia

sinus issues1 - social support1 - play-up programme1 - cotard's syndrome1 - diagnosis of ad1 - thiamin deficiency1 - people with parkinsons1 - vitamin b12 deficiency1 - blast-induced traumatic brain injury1 - leg tremors1 - islet amyloid polypeptide1 - ireland's national dementia strategy1 - slower overall movement1 - exposure to ddt1 - immune globulin1 - development of alzheimer's1 - pdd3 - carl schneider1 - cytokine storm1 - glucose hypometabolism1 - concept of dementia1 - amyloid-beta peptides1 - vci1 - protein alpha-synuclein1 - mild tbi1 - alzheimers patients3 - earliest stages of alzheimers disease1 - alzheimer's proteins1 - protease enzyme1 - sleep1 -